Joshua K. Park - Concepedia

Author

Joshua K. Park

National Institute on Alcohol Abuse and Alcoholism ORCID

Also Known As

Joshua K Park, Joshua K. Park, Joshua Kee Park, Park, Joshua K.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Icahn School of Medicine at Mount Sinai Johns Hopkins University National Human Genome Research Institute

About

Joshua K. Park is an author at National Institute on Alcohol Abuse and Alcoholism specializing in medicine, pharmacology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	442
2	Engineering	1	1	13
3	Health Sciences	1	1	58
4	Public Health	1	1	145
5	Social Sciences	1	1	92

Joshua K. Park

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer Amira Elgogary, Qingguo Xu, Brad Poore, Proceedings of the National Academy of Sciences	2016	223
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts Iain S. Forrest, Ben Omega Petrazzini, Áine Duffy, The Lancet Cardiovascular DiseaseCoronary UnitCardiologyBiostatisticsLongitudinal Cohorts	2022	145
Network analyses identify liver‐specific targets for treating liver diseases Sunjae Lee, Cheng Zhang, Zhengtao Liu, Molecular Systems Biology	2017	117
Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice Elliot D. Mock, Mohammed Ahmed Mustafa, Ozge Gunduz‐Cinar, Nature Chemical Biology Knockout MouseEmotional BehaviorBehavioral NeuroscienceMedicineBehavioral Pharmacology	2020	92
Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis Bernadette R. Gochuico, Malliga R. Iyer, Tony Jourdan, JCI Insight InflammationAsthmaCannabis UseInflammatory Lung DiseaseAdvanced Lung Disease	2017	83
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis Malliga R. Iyer, Ziyi Liu, Zongxian Cao, JCI Insight	2016	81
Cannabinoid‐1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy Tony Jourdan, Joshua K. Park, Zoltán V. Varga, Diabetes Obesity and Metabolism	2017	68
Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis Grzegorz Godlewski, Nathan J. Coffey, Jie Liu, Cell Metabolism Cannabis UseHealth SciencesAddictionMedicinePhysiology	2019	58
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes Tony Jourdan, Gergő Szanda, Grzegorz Godlewski, Diabetes	2017	43
The Heterogeneity of Lipid Metabolism in Cancer Joshua K. Park, Nathan J. Coffey, Aaron Limoges, Advances in experimental medicine and biology	2021	38

Page 1